Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 26, 2024

BUY
$0.55 - $0.88 $14,681 - $23,490
26,694 New
26,694 $19,000
Q3 2022

Nov 07, 2022

BUY
$1.57 - $2.38 $58,975 - $89,402
37,564 New
37,564 $51,000
Q1 2021

May 19, 2021

SELL
$3.33 - $6.5 $147,805 - $288,509
-44,386 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$2.88 - $4.33 $127,831 - $192,191
44,386 New
44,386 $173,000
Q4 2019

Feb 04, 2020

SELL
$4.28 - $5.95 $86,135 - $119,743
-20,125 Closed
0 $0
Q3 2019

Nov 20, 2019

BUY
$2.97 - $6.42 $59,771 - $129,202
20,125 New
20,125 $113,000
Q2 2019

Aug 13, 2019

SELL
$2.93 - $3.6 $31,626 - $38,858
-10,794 Closed
0 $0
Q1 2019

Apr 12, 2019

BUY
$2.19 - $3.45 $23,638 - $37,239
10,794 New
10,794 $35,000
Q4 2018

Jan 16, 2019

SELL
$1.7 - $2.88 $32,468 - $55,005
-19,099 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$1.57 - $2.59 $29,985 - $49,466
19,099 New
19,099 $49,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $36.1M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.